Scotland is offering a slew of facilities for Indian pharma and biotech companies to conduct clinical trials, according to Roma Bussi, Country Director – India, Scottish Development International (SDI).
Scotland was an ideal location for conducting clinical trials in view of the simple regulatory procedures, eco-system and expertise, she told newspersons here today. She is in the city along with a business delegation from Scotland to take part in the BioAsia 2014 scheduled for next week.
“Though the cost of clinical trials per patient is higher in Scotland when compared to India, the advantages include regulatory clearance within 90 days, among others,’’ she said.